Glenmark Pharmaceuticals USA
Pharmaceutical manufacturing
Based in NJ
AI Overview
With $4.2M in lobbying spend across 27 quarterly filings, Glenmark Pharmaceuticals USA is a significant lobbying presence. Their lobbying covers 2 issue areas. Active from 2018 to 2024.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $842K |
| 2019 | $1.0M |
| 2020 | $897K |
| 2021 | $897K |
| 2022 | $601K |
| 2023 | $0 |
| 2024 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Glenmark Pharmaceuticals USA disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid
Prescription drug costs
Medicaid Generics Penalty, Medicaid Rebates
Medicaid Generics Penalty
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.